MCKESSON CORP shareholders Q2 2022

MCKESSON CORP's ticker is MCK and the CUSIP is 58155Q103. A total of 1,156 filers reported holding MCKESSON CORP in Q2 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.

MCKESSON CORP shareholders Q2 2022
NameSharesValueWeighting ↓
MTM Investment Management, LLC 12,120$3,994,0002.16%
SIGNATURE ESTATE & INVESTMENT ADVISORS LLC 126,660$41,318,0002.09%
Tekla Capital Management LLC 160,722$52,429,0002.06%
BECKER CAPITAL MANAGEMENT INC 124,264$40,536,0001.95%
BUTENSKY & COHEN FINANCIAL SECURITY, INC 14,504$4,731,0001.94%
HUDSON EDGE INVESTMENT PARTNERS INC. 15,866$5,176,0001.89%
Heron Bay Capital Management 9,388$3,062,0001.86%
Aquila Investment Management LLC 8,000$2,610,0001.85%
Peachtree Investment Partners, LLC 9,109$2,971,0001.85%
CULBERTSON A N & CO INC 25,913$8,453,0001.83%
Endurant Capital Management LP 15,984$5,214,0001.83%
ASAHI LIFE ASSET MANAGEMENT CO., LTD. 20,791$6,782,0001.82%
Royal Harbor Partners, LLC 8,060$2,629,0001.80%
Ironwood Investment Counsel, LLC 19,101$6,230,0001.75%
ACADIAN ASSET MANAGEMENT LLC 1,005,321$327,948,0001.68%
Dorsey Wright & Associates 17,413$5,680,0001.66%
CAAS CAPITAL MANAGEMENT LP 100,000$32,621,0001.63%
CAAS CAPITAL MANAGEMENT LP 100,000$32,621,0001.63%
Cairn Investment Group, Inc. 6,365$2,076,0001.61%
Pflug Koory, LLC 8,541$2,786,0001.61%
About MCKESSON CORP

McKesson Corp is a leading healthcare services and information technology company that provides innovative solutions to improve patient care and reduce healthcare costs. The company operates in three segments: pharmaceutical distribution, technology solutions, and medical-surgical solutions.

In the pharmaceutical distribution segment, McKesson is the largest distributor of pharmaceuticals and medical supplies in North America. The company's technology solutions segment provides software and analytics to help healthcare providers improve patient outcomes and reduce costs. The medical-surgical solutions segment offers medical-surgical supplies and equipment to healthcare providers.

McKesson has a strong financial position with a market capitalization of over $30 billion and a revenue of $231 billion in 2020. The company has a diverse customer base, including hospitals, pharmacies, and healthcare providers.

McKesson has been actively involved in the fight against the COVID-19 pandemic. The company has been working with the government and healthcare providers to distribute vaccines and medical supplies to combat the virus. McKesson has also been providing support to healthcare providers by offering telehealth solutions and other digital tools to help them manage patient care remotely.

In conclusion, McKesson Corp is a leading healthcare services and information technology company that is committed to improving patient care and reducing healthcare costs. With its strong financial position and diverse customer base, the company is well-positioned to continue its growth and innovation in the healthcare industry.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists MCKESSON CORP's shareholders in Q2 2022. To view MCKESSON CORP's shareholder history, click here.